Cibc Private Wealth Group, LLC Red Hill Biopharma Ltd. Transaction History

Cibc Private Wealth Group, LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2020 Feb 12, 2021	SELL	$7.81 - $10.39 $93,720 - $124,680	-12,000 Closed	0 $0
Q3 2020 Oct 29, 2020	BUY	$6.34 - $10.83 $76,080 - $129,960	12,000 New	12,000 $123,000
Q2 2020 Aug 13, 2020	SELL	$4.6 - $8.6 $55,199 - $103,200	-12,000 Closed	0 $0
Q1 2020 May 15, 2020	BUY	$3.51 - $6.17 $42,120 - $74,040	12,000 New	12,000 $54,000

40.4K

Ticker RDHL
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 63,823,500
Market Cap $465M
Description
RedHill Biopharma Ltd., a specialty biopharmaceutical company, primarily focuses on gastrointestinal and infectious diseases. The company promotes gastrointestinal drugs, including Movantik for opioid-induced constipation in adults with chronic non-cancer pain; Talicia for the treatment of Helicobacter pylori infection in adults; and Aemcolo for...

Get notified when there are updates to the investment portfolio of Cibc Private Wealth Group, LLC, based on Form 13F filings with the SEC.

Stay updated on Cibc Private Wealth Group, LLC with notifications on news.